BeStock  
Stocks › ADRX

Adarx Pharmaceuticals ADRX

US equityMarket cap rank #2804
$19.05 +$0.80 (+4.38%)
Pre-market · Oct 6, 7:10 am ET · After hours $19.05 0.00%
Open$18.25
Prev close$18.25
Day range$17.30 – $19.40
Volume914.0K
Market cap$1.95B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$746,000.00+258.7% YoY
Operating profit-$29.89M-41.5% YoY
Net profit-$25.76M-42.4% YoY
Diluted EPS-$0.25-4.9% YoY
Free cash flow-$27.56M-108.8% YoY
Operating cash flow-$27.19M

Revenue, last 4 quarters

$0.0Mar '25$208.0KJun '25$2.1MMar '26$746.0KJun '26

Net profit, last 4 quarters

$-15.6MMar '25$-18.1MJun '25$-22.7MMar '26$-25.8MJun '26

Diluted EPS by quarter

-0.21Mar '25-0.24Jun '25-0.22Mar '26-0.25Jun '26

Free cash flow by quarter

$-13.2MMar '25$312.5MJun '25$-22.8MMar '26$-27.6MJun '26

Profitability & balance sheet

Operating margin-1,735.0%
Net margin-1,434.1%
Return on assets-19.3%
Current ratio12.98
Liabilities / assets139.8%
Cash & investments$480.00M
Total debt$6.03M
Net cash (debt)$473.97M

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q2 2025 Q1
Net cash flow from investing $21.76M $19.96M -$263.17M $13.94M
-Change In Other Working Capital -$746,000.00 -$2.14M – –
-Change in Other Current Liabilities -$430,000.00 -$412,000.00 -$370,000.00 -$128,000.00
-Change in Other Current Assets -$1.57M -$30,000.00 -$91,000.00 -$1.32M
-Change in Payables and Accrued Expense $514,000.00 $730,000.00 $698,000.00 $1.33M
Change in Working Capital -$3.59M -$1.36M $330.53M $1.64M
Depreciation & Depletion & Amortization $735,000.00 $720,000.00 $626,000.00 $514,000.00
Net cash flow from continuing operations -$27.19M -$22.68M $313.44M -$12.71M
Operating Cash Flow -$27.19M -$22.68M $313.44M -$12.71M
Net Income from Continuing Operations -$25.76M -$22.67M -$18.09M -$15.55M
Financing Cash Flow $6,000.00 $2,000.00 $83,000.00 $0.00
Net Cash Flow from Continuing Financing Activities $6,000.00 $2,000.00 $83,000.00 $0.00
Net Cash Flow from Continuing Investing Activities $21.76M $19.96M -$263.17M $13.94M
Net PPE Purchase and Sale -$367,000.00 -$77,000.00 -$992,000.00 -$497,000.00
Net Investment Purchase and Sale $22.13M $20.04M -$262.17M $14.44M
Proceeds from Stock Option Exercised $6,000.00 $2,000.00 $83,000.00 $0.00
Net Change in Cash -$5.42M -$2.72M $50.36M $1.24M
-Change in Prepaid Assets -$1.37M $493,000.00 -$4.50M $1.75M
Free Cash Flow -$27.56M -$22.76M $312.45M -$13.20M
Effect of Exchange Rate Changes $47,000.00 $61,000.00 $18,000.00 -$6,000.00
Ending Cash Balance $58.48M $63.86M $65.65M $15.27M
Beginning Cash Balance $63.86M $66.52M $15.27M $14.03M

Income statement

Line item 2026 Q2 2026 Q1 2025 Q2 2025 Q1
Operating Expense $30.64M $29.20M $21.33M $17.89M
Total Operating Revenue $746,000.00 $2.14M $208,000.00 $0.00
Total Revenue as Reported $746,000.00 $2.14M $208,000.00 $0.00
Selling and Admin Expenses $5.90M $5.62M $4.26M $5.00M
-General & Admin Expense $5.90M $5.62M $4.26M $5.00M
Research & Development $24.74M $23.58M $17.07M $12.89M
Diluted EPS -$0.25 -$0.22 -$0.24 -$0.21
Basic EPS -$0.25 -$0.22 -$0.24 -$0.21
Net Income to Common Stockholders -$25.76M -$22.67M -$18.09M -$15.55M
Net Income to Parent Company -$25.76M -$22.67M -$18.09M -$15.55M
Profit from Continuing Operations -$25.76M -$22.67M -$18.09M -$15.55M
Net Profit -$25.76M -$22.67M -$18.09M -$15.55M
Pretax Profit -$25.76M -$22.67M -$18.09M -$15.55M
Other Non-Operating Income (Expenses) $355,000.00 $411,000.00 $553,000.00 $72,000.00
Other Income (Expense) $355,000.00 $411,000.00 $553,000.00 $72,000.00
Net Non-Operating Interest Income (Expense) $3.78M $3.98M $2.48M $2.27M
Operating Profit -$29.89M -$27.06M -$21.12M -$17.89M
Non-Operating Interest Income $3.78M $3.98M $2.48M $2.27M

Balance sheet

Line item 2025 ANNUAL 2024 ANNUAL
Convertible preferred securities $357.62M $357.62M
Non-Current Deferred Liabilities $314.99M $0.00
-Long Term Capital Lease Obligation $6.03M $3.54M
Total Non-Current Liabilities $679.43M $361.66M
Other Non-Current Liabilities $781,000.00 $505,000.00
Total Equity -$202.26M -$137.15M
Stockholders' Equity -$202.26M -$137.15M
Capital Stock $0.00 $0.00
-Common Stock $0.00 $0.00
Additional Paid-In Capital $16.49M $10.13M
Retained Earnings -$220.70M -$147.61M
Gains/Losses Not Affecting Retained Earnings $1.96M $335,000.00
Current Accrued Expenses $3.49M $3.50M
Current Deferred Liabilities $16.56M $0.00
-Current Capital Lease Obligation $1.71M $794,000.00
Short-Term Debt and Capital Lease Obligation $1.71M $794,000.00
Long Term Debt and Capital Lease Obligation $6.03M $3.54M
Total Assets $507.66M $233.45M
Total Current Assets $493.38M $225.67M
Cash and Cash Equivalents & Short-Term Investments $480.00M $219.48M
-Cash and Cash Equivalents $66.52M $14.03M
-Short Term Investments $413.48M $205.44M
Other Current Assets $13.38M $6.19M
Total Non-Current Assets $14.28M $7.79M
Net PPE $12.07M $7.13M
-Accounts Payable $5.84M $1.35M
Payables $5.84M $1.35M
Total Current Liabilities $30.49M $8.94M
Total Liabilities $709.91M $370.60M
Other Non-Current Assets $2.21M $660,000.00
-Accumulated Depreciation -$3.54M -$2.54M
-Gross PPE $15.61M $9.67M

Discussion

No comments yet — be the first to weigh in on ADRX.

Leave a comment

Scroll to Top